
Avantor (AVTR) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
6.8B
Gross Profit
2.3B
33.60%
Operating Income
638.2M
9.41%
Net Income
711.5M
10.49%
EPS (Diluted)
$1.04
Balance Sheet Metrics
Total Assets
12.1B
Total Liabilities
6.2B
Shareholders Equity
6.0B
Debt to Equity
1.03
Cash Flow Metrics
Operating Cash Flow
1.2B
Free Cash Flow
692.0M
Revenue & Profitability Trend
Avantor Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 6.8B | 7.0B | 7.5B | 7.4B | 6.4B |
Cost of Goods Sold | 4.5B | 4.6B | 4.9B | 4.9B | 4.3B |
Gross Profit | 2.3B | 2.4B | 2.6B | 2.5B | 2.1B |
Operating Expenses | 1.6B | 1.5B | 1.5B | 1.5B | 1.4B |
Operating Income | 638.2M | 857.2M | 1.1B | 972.2M | 706.8M |
Pre-tax Income | 853.9M | 410.5M | 851.1M | 753.0M | 62.3M |
Income Tax | 142.4M | 89.4M | 164.6M | 180.4M | -54.3M |
Net Income | 711.5M | 321.1M | 686.5M | 572.6M | 116.6M |
EPS (Diluted) | $1.04 | $0.47 | $1.01 | $0.85 | $0.09 |
Income Statement Trend
Avantor Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | 2.1B | 2.4B | 2.7B | 2.5B | 2.2B |
Non-Current Assets | 10.0B | 10.6B | 10.8B | 11.4B | 7.7B |
Total Assets | 12.1B | 13.0B | 13.5B | 13.9B | 9.9B |
Liabilities | |||||
Current Liabilities | 2.0B | 1.5B | 1.7B | 1.5B | 1.2B |
Non-Current Liabilities | 4.2B | 6.2B | 7.0B | 8.2B | 6.0B |
Total Liabilities | 6.2B | 7.7B | 8.6B | 9.7B | 7.2B |
Equity | |||||
Total Shareholders Equity | 6.0B | 5.3B | 4.9B | 4.2B | 2.7B |
Balance Sheet Composition
Avantor Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 711.5M | 321.1M | 686.5M | 572.6M | 116.6M |
Operating Cash Flow | 1.2B | 620.1M | 756.0M | 884.3M | 544.1M |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Investing Cash Flow | 587.7M | 2.7M | 23.8M | -4.0B | 2.5M |
Financing Activities | |||||
Dividends Paid | 0 | 0 | -32.4M | -64.6M | -64.6M |
Financing Cash Flow | -1.4B | -862.0M | -666.0M | 3.1B | -803.1M |
Free Cash Flow | 692.0M | 723.6M | 710.2M | 842.5M | 868.2M |
Cash Flow Trend
Avantor Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
13.05
Forward P/E
12.01
Price to Book
1.52
Price to Sales
1.38
PEG Ratio
12.01
Profitability Ratios
Profit Margin
10.70%
Operating Margin
8.21%
Return on Equity
12.52%
Return on Assets
3.53%
Financial Health
Current Ratio
1.12
Debt to Equity
67.34
Beta
1.05
Per Share Data
EPS (TTM)
$1.04
Book Value per Share
$8.95
Revenue per Share
$9.83
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
avtr | 9.2B | 13.05 | 1.52 | 12.52% | 10.70% | 67.34 |
Intuitive Surgical | 189.7B | 77.39 | 11.09 | 15.96% | 28.41% | 0.00 |
Becton, Dickinson | 50.0B | 33.87 | 1.98 | 5.89% | 7.18% | 76.34 |
Repligen | 6.9B | 511.11 | 3.49 | -1.16% | -3.53% | 34.44 |
Stevanato | 6.4B | 44.23 | 4.52 | 9.14% | 11.16% | 27.86 |
Merit Medical | 5.6B | 46.74 | 3.94 | 9.16% | 8.81% | 57.24 |
Financial data is updated regularly. All figures are in the company's reporting currency.